A look at some of the most promising approaches under development at Baylor College of Medicine to diagnose and treat disease.

Center for Drug Discovery
Developing small molecules and other therapies for drug development.
Matthew L. Anderson, M.D., Ph.D.
Treating ovarian cancer with microRNAs.
Christine Beeton, Ph.D.
Potassium channel modulation as a therapeutic strategy for chronic inflammatory disease.
Miguel Cruz, Ph.D.
Developing a novel treatment for systemic inflammation.
Benjamin J. Frankfort, M.D., Ph.D.
A non-Invasive device for early diagnosis of glaucoma and other ophthalmic diseases.
Mauro Costa-Mattioli, Ph.D.
Developing compounds to enhance cognitive function.
Hoang Nguyen, Ph.D.
Developing a novel therapeutic strategy to accelerate wound repair.
Yongcheng Song, Ph.D.
Developing novel pharmacological interventions to treat leukemia.